Denis Raccah

Summary

Country: France

Publications

  1. doi request reprint Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus
    D Raccah
    Department of Diabetology, University Hospital Sainte Marguerite, Marseille, France
    Diabetes Obes Metab 10:76-82. 2008
  2. pmc Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study
    Denis Raccah
    University Hospital Sainte Marguerite, Marseille, France
    Diabetes Care 32:2245-50. 2009
  3. ncbi request reprint When basal insulin therapy in type 2 diabetes mellitus is not enough--what next?
    Denis Raccah
    University Hospital Sainte Marguerite, Marseille, France
    Diabetes Metab Res Rev 23:257-64. 2007
  4. doi request reprint Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment
    L Molines
    Department of Nutrition, Metabolic Diseases and Endocrinology, Sainte Marguerite Hospital, 270, boulevard de Sainte Marguerite, 13274 Marseille Cedex 9, France
    Diabetes Metab 36:251-5. 2010
  5. doi request reprint Aggressive multimodal therapy of sporadic malignant insulinoma can improve survival: a retrospective 35-year study of 12 patients
    A Begu-Le Corroller
    Service de nutrition maladies métaboliques endocrinologie, Hopital de la Timone, 264, rue Saint Pierre, 13005 Marseille, France
    Diabetes Metab 34:343-8. 2008
  6. ncbi request reprint Importance of blood glucose management in the multifactorial approach of absolute cardiovascular risk in type 2 diabetes: the lessons from the Steno 2 study
    D Raccah
    Service de Nutrition Endocrinologie Maladies Métaboliques, Hopital Sainte Marguerite, CHU de Marseille, Marseille, France
    Diabetes Metab 32:2S48-51. 2006
  7. ncbi request reprint Insulin initiation in type 2 diabetic patients admitted in hospital in France and follow-up at 1 year
    D Raccah
    Service de Nutrition, Endocrinologie et Maladies Métaboliques, Hopital Sainte Marguerite, Marseille, France
    Diabetes Metab 32:244-50. 2006
  8. ncbi request reprint Metabolic factors and the foveal avascular zone of the retina in diabetes mellitus
    J Conrath
    Ophthalmology Department, Hopital de la Timone, France
    Diabetes Metab 31:465-70. 2005
  9. ncbi request reprint [Genetics of diabetic complications: peripheral neuropathy]
    D Raccah
    Service de Nutrition, Endocrinologie, Maladies Metaboliques, CHU La Timone, F 13385 Marseille cedex 05
    Ann Endocrinol (Paris) 65:S5-9. 2004
  10. ncbi request reprint Foveal avascular zone in diabetic retinopathy: quantitative vs qualitative assessment
    J Conrath
    Ophthalmology Department, Timone Hospital, Marseille, France
    Eye (Lond) 19:322-6. 2005

Collaborators

Detail Information

Publications20

  1. doi request reprint Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus
    D Raccah
    Department of Diabetology, University Hospital Sainte Marguerite, Marseille, France
    Diabetes Obes Metab 10:76-82. 2008
    ..Prospective studies are underway to further examine this concept and determine the benefit of this approach not only on overall glycaemic control but also on cardiovascular risk...
  2. pmc Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study
    Denis Raccah
    University Hospital Sainte Marguerite, Marseille, France
    Diabetes Care 32:2245-50. 2009
    ..To compare the improvements in glycemic control associated with transitioning to insulin pump therapy in patients using continuous glucose monitoring versus standard blood glucose self-monitoring...
  3. ncbi request reprint When basal insulin therapy in type 2 diabetes mellitus is not enough--what next?
    Denis Raccah
    University Hospital Sainte Marguerite, Marseille, France
    Diabetes Metab Res Rev 23:257-64. 2007
    ..This strategy offers a simple, stepwise approach to progress from basal insulin to a basal-bolus regimen. Studies are needed to validate this method and better define specific titration tactics...
  4. doi request reprint Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment
    L Molines
    Department of Nutrition, Metabolic Diseases and Endocrinology, Sainte Marguerite Hospital, 270, boulevard de Sainte Marguerite, 13274 Marseille Cedex 9, France
    Diabetes Metab 36:251-5. 2010
    ..As the cornerstone of treatment remains any method that avoids weight-bearing on the foot, the primary importance of the RANK/RANK-L/OPG signalling pathway is that it opens up the field to new treatment strategies for the future...
  5. doi request reprint Aggressive multimodal therapy of sporadic malignant insulinoma can improve survival: a retrospective 35-year study of 12 patients
    A Begu-Le Corroller
    Service de nutrition maladies métaboliques endocrinologie, Hopital de la Timone, 264, rue Saint Pierre, 13005 Marseille, France
    Diabetes Metab 34:343-8. 2008
    ....
  6. ncbi request reprint Importance of blood glucose management in the multifactorial approach of absolute cardiovascular risk in type 2 diabetes: the lessons from the Steno 2 study
    D Raccah
    Service de Nutrition Endocrinologie Maladies Métaboliques, Hopital Sainte Marguerite, CHU de Marseille, Marseille, France
    Diabetes Metab 32:2S48-51. 2006
    ..This explains the increased prevalence of cardiovascular morbi-mortality in diabetic patients, in particular type 2 diabetes. Multifactorial treatment can reduce the cardiovascular risk by 55%, as the Steno 2 study demonstrated...
  7. ncbi request reprint Insulin initiation in type 2 diabetic patients admitted in hospital in France and follow-up at 1 year
    D Raccah
    Service de Nutrition, Endocrinologie et Maladies Métaboliques, Hopital Sainte Marguerite, Marseille, France
    Diabetes Metab 32:244-50. 2006
    ..The objective was to assess the patients' profile, the treatments proposed during hospital stay and after one year...
  8. ncbi request reprint Metabolic factors and the foveal avascular zone of the retina in diabetes mellitus
    J Conrath
    Ophthalmology Department, Hopital de la Timone, France
    Diabetes Metab 31:465-70. 2005
    ..To study the foveal avascular zone (FAZ) of the central retina in diabetic patients with retinopathy having undergone metabolic evaluation...
  9. ncbi request reprint [Genetics of diabetic complications: peripheral neuropathy]
    D Raccah
    Service de Nutrition, Endocrinologie, Maladies Metaboliques, CHU La Timone, F 13385 Marseille cedex 05
    Ann Endocrinol (Paris) 65:S5-9. 2004
    ..The main studies and data are reviewed in this Article. The identification of candidate-genes should allowed, in the future, to better identify and manage diabetic patients at-risk for peripheral neuropathy...
  10. ncbi request reprint Foveal avascular zone in diabetic retinopathy: quantitative vs qualitative assessment
    J Conrath
    Ophthalmology Department, Timone Hospital, Marseille, France
    Eye (Lond) 19:322-6. 2005
    ..To describe the relations between foveal avascular zone (FAZ) size and outline in patients presenting diabetic retinopathy...
  11. ncbi request reprint Genetic and environmental regulation of Na/K adenosine triphosphatase activity in diabetic patients
    M F Jannot
    Diabetes Department, University Hospital Timone, Marseille, France
    Metabolism 51:284-91. 2002
    ..This may explain the high relative risk of developing the neuropathy observed in type 1 diabetic patients bearing the variant allele...
  12. pmc C-peptide, Na+,K(+)-ATPase, and diabetes
    P Vague
    Departement de Nutrition Endocrinologie Maladies Métaboliques, CHU Timone, Marseille, France
    Exp Diabesity Res 5:37-50. 2004
    ..Because the defect in Na+,K(+)-ATPase activity is also probably involved in the development of diabetic nephropathy and cardiomyopathy, physiological C-peptide infusion could be beneficial for the prevention of diabetic complications...
  13. pmc Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients
    Fabrice Armougom
    URMITE UMR CNRS 6236, IRD 3R198, Universite de la Mediterranee, Faculte de Medecine, and Nutrition and Diabetology Department, University Hospital Sainte Marguerite, Marseille, France
    PLoS ONE 4:e7125. 2009
    ..The roles of the archaeon Methanobrevibacter smithii and Lactobacillus species have not been described in these studies...
  14. ncbi request reprint A randomized trial of low-protein diet in type 1 and in type 2 diabetes mellitus patients with incipient and overt nephropathy
    Bertrand Dussol
    centre d investigation clinique, INSERM APHM, Marseille, France
    J Ren Nutr 15:398-406. 2005
    ..8 g/kg/day) with a usual-protein diet...
  15. ncbi request reprint Glycemic and insulinemic meal responses modulate postprandial hepatic and intestinal lipoprotein accumulation in obese, insulin-resistant subjects
    Amandine Harbis
    UMR 476 INSERM 1260 INRA, Human Nutrition and Lipids, Faculty of Medecine, Universite de la Mediterranee, Marseille, France
    Am J Clin Nutr 80:896-902. 2004
    ..Exacerbated postprandial lipemia is a risk factor for cardiovascular disease and is linked to insulin status. Limited data on the effect of dietary carbohydrate on postprandial lipoprotein accumulation are available...
  16. ncbi request reprint Alternatives routes of insulin delivery
    V Lassmann-Vague
    Service d endocrinologie, Maladies metaboliques et nutrition, Hopital Sainte Marguerite, Marseille, France
    Diabetes Metab 32:513-22. 2006
    ....
  17. ncbi request reprint Six-year follow-up of a cohort of 203 patients with diabetes after screening for silent myocardial ischaemia
    S Sejil
    Endocrinology Nutrition Metabolic Disease Department, Timone University Hospital Centre, Marseille, France
    Diabet Med 23:1186-91. 2006
    ..To determine the prognosis of patients with Type 1 or Type 2 diabetes, 6 years after screening for silent myocardial ischaemia (SMI)...
  18. ncbi request reprint Interference of dapsone in HbA1c monitoring of a diabetic patient with polychondritis
    J Serratrice
    Service de Medecine Interne, CHU Timone, Marseille, France
    Diabetes Metab 28:508-9. 2002
  19. ncbi request reprint Decreased Na/K ATPase ouabain binding sites in red blood cells of patients with insulin-dependent diabetes and healthy north African control subjects: relationship with diabetic neuropathy
    D Raccah
    Diabetology Laboratory, Timone University Medical Center, Marseille, France
    Horm Metab Res 28:128-32. 1996
    ....
  20. ncbi request reprint Comparison of the effects of captopril and nicardipine on insulin sensitivity and thrombotic profile in patients with hypertension and android obesity. CaptISM Study Group. Captopril Insulin Sensitivity Multicenter Study Group
    D Raccah
    , Marseille, France
    Am J Hypertens 7:731-8. 1994
    ..1 +/- 98.6 microIU x h/mL (4.8%) for nicardipine (P = .072). Changes in peak insulin values were -18.3 +/- 86.2 microIU/mL (-14%) for captopril v 6.7 +/- 79.4 microIU/mL (6.6%) for nicardipine (P = .070).(ABSTRACT TRUNCATED AT 250 WORDS)..